The partnership also involves TransPerfect’s Trial Interactive Portal Technology, which is already being used by biopharmaceutical firms for electronic Trial Master Files, investigator portals, IRB and central laboratory solutions.
The Trial Interactive Portal Solution will enable direct safety information collection on a global basis from investigative site personnel via multiple sources, including fax, email, direct-entry, or by telephonic means, into a secure data portal.
The approach will speed safety data exchange between safety teams and reporters while enhancing sponsors’ ability to support multiple stakeholders globally.
The portal is fully compatible with Sentrx’s drug safety solution SaPh, which provides turnkey Argus Safety instance management in a hassle-free, hosted deployment.
Sentrx president and GM Michael O’Gorman said their collaboration with Trial Interactive has produced a fully compliant safety portal platform to enhance workflow efficiency.
TransPerfect Life Sciences Solutions division GM Michael Smyth said the addition of the safety module in Trial Interactive, developed with Sentrx, provides the ability to truly offer global Pharmacovigilance support to pharmaceutical, biotechnology, and medical device companies as well as CROs.